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Abstract
In the normal peripheral nervous system, Schwann cells (SCs) are present in 
two different states of differentiation: myelinating SCs that surround large-caliber 
axons, forming myelin sheath, and non-myelinating SCs that surround more 
small-caliber axons forming Remak bundles. Under pathological conditions (injury 
or inflammation), SCs, with a remarkable plasticity, undergo phenotypic transfor-
mations, downregulating the production of myelin proteins mRNAs, upregulating 
neurotrophic factors and cytokines, thus promoting the axonal regeneration. 
Dedifferentiated SCs activate the protein degradation, participating in the demy-
elination process and clearance of myelin debris; attract macrophages helping 
wound healing; proliferate to replace lost cells; guide axonal growth; and protect 
against secondary axonal damage. Thus, SC functions have a critical contribution to 
regeneration processes that occur in peripheral nerve after injury.
Keywords: Schwann cell plasticity, dedifferentiated Schwann cells, peripheral nerve 
regeneration, myelin recovery
1. Introduction
Schwann cells (SCs) are glial cells present in the peripheral nerve system (PNS). 
The name was given in honor of the German scientist Theodore Schwann, who 
discovered them in the nineteenth century [1] although they were not the main 
subject of his research. At that time it was thought that this type of cells is very com-
plex and that the cells merge to supply peripheral nerves. Ramon y Cajal, only about 
100 years later, discovered the true structure of the peripheral nerves, composed of 
axons and SCs that are in a symbiotic connection with it [2]. In the following years, 
with the evolution of electron microscopy, the study of SC morphology has devel-
oped continuously, leading to a better understanding of their complex biology.
It is known that nerves in PNS are much easier to regenerate than those in the 
central nervous system (CNS). Ramon y Cajal sensed very well that there is a 
“symbiosis” between the axon and the Schwann cells. Kidd et al. [3] described the 
Schwann cell as one of the largest and most complex cells in the body, which can 
develop and evolve rapidly after injury. The origin of the Schwann cell is in the 
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neural crest, and this differentiation is made by the regulation of Sox10 but also in 
the presence of Notch and endothelin signaling [4, 5].
After a peripheral nerve lesion, a series of cellular changes occur at both axons 
and Schwann cells, a phenomenon known as Wallerian degeneration: axonal degen-
eration and myelin destruction, followed by a dedifferentiation (an immature-like 
phenotype of SCs) and proliferation of Schwann cells [6].
The purpose of this chapter is to highlight the extremely important role of the 
Schwann cell in the regeneration of the peripheral nerve and its extraordinary 
plasticity in order to ensure this phenomenon.
2. Peripheral nerve injury
What does peripheral nerve injury mean? This could mean a mechanical trauma, 
transection or  crush, or a pathological condition, when could be affected sensory 
nerves, motor nerves or autonomic nerves. A peripheral neuropathy may affect one 
or many nerves, axon, or myelin in the first stage.
In the nerve transection, all nerve fibers are affected, while in a disease 
manifestation, only a number of nerve fibers are affected, others being normal 
(Figures 2A and 4).
Very briefly, in peripheral neuropathies, it may be an axonal primary damage or 
a myelin sheath primary damage. After a period both components of the nerve fiber 
are affected.
Primary axonal degeneration, whether it is nerve transection or a pathological 
manifestation, is essentially the same: it starts with a Wallerian degeneration in the dis-
tal part of nerve (Figure 1), following the myelin destruction. On semithin transverse 
Figure 1. 
Wallerian degeneration. After injury, axon and myelin sheath in the distal stump degenerate. Macrophages 
migrate to the site of lesion and with proliferating Schwann cells remove myelin debris. After the debris 
has been removed, dedifferentiated Schwann cells align forming bands of Bungner, guiding axonal sprout 
regeneration.
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sections (Figure 2B and C) and in electron microscopy images (Figure 3), the affected 
nerve fibers are seen to be in a process of necrobiosis. In electron microscopy images, 
autophagic vacuoles are seen, near the axon (Figure 3A) or in the exterior layer of SC, 
Figure 2. 
Peripheral nerve pathological modifications (sural nerve biopsy): (A) a very mild affected nerve, with a 
normal fiber density; some myelinated fibers with small and medium mean diameter with demyelination;  
(B) a severe axonal destruction, with disappearance of many large diameter axons and with a low-fiber 
density; a degenerated axon is present; (C) many degenerated axons and demyelination present in the rest of 
myelinated fibers; (D) a very severe neuropathy with disappearance of most of the myelinated fibers; (E) some 
small myelinated axons with onion bulbs; (F) a hypermyelinated fiber in an HNPP case (tomacula) in the 
center of the image; (G) regeneration aspect: cluster of small axons (arrow). Semithin cross sections stained 
with toluidine blue; (under oil immersion – 60× Objective).
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under the basal lamina (Figure 3B and C) and macrophages (Figure 3D). After the 
destruction of the nerve fiber, only irregular structures of myelin residues can be seen 
(Figure 3E) or myelin debris like ovoids and balls (Figure 4B and C). If it is a chronic 
process, many nerve fibers disappear, the density of myelinated fibers being very low 
(Figure 2D and E). When the myelin is affected in the first step, not all Schwann cells 
are suffering in the same time. One internode with a very thin sheath between two nor-
mal internodes may be observed: segmental demyelination (Figure 4A and B). When a 
myelin protein, PMP22, is genetically affected, in hereditary neuropathy with pressure 
palsies (HNPP), the nerve biopsy shows demyelination and focal hypermyelination 
structures, tomacula (sausage-like) (Figures 2F and 4D). In hypertrophic neuropa-
thies, like Charcot-Marie-Tooth disease type 1A (CMT 1A) and chronic inflammatory 
demyelinating polyneuropathy (CIDP), some structures named “onion bulbs” are 
present, a result of concentric layers of Schwann cell processes and collagen around the 
axons (Figure 2E). It is a repetitive segmental demyelination and myelin regeneration.
Figure 3. 
Electron microscopy aspects of axonal degeneration (sural nerve biopsy). (A) A myelinated axon showing an 
autophagic vacuole between axon and myelin sheath. (B) A myelinated axon with an autophagic vacuole 
in the Schwann cell exterior cytoplasma: small myelin debris are seen. (C) The same aspect: an autophagic 
Schwann cell with many smaller or bigger fragments of myelin inside. (D) A macrophage with lipid droplets 
is present near myelinated axons. (E) Total myelin degradation; only irregular laminated structure is present, 
with no axon (cross sections; bar = 2 μm).
5Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury
DOI: http://dx.doi.org/10.5772/intechopen.91805
After a segmental demyelination, along the affected internode, several Schwann 
cells arrive which begin to remyelinate this portion, the sign of remyelination being 
more short internodes (Figure 5).
The sign of axonal regeneration is observed on semithin sections and consists 
of the presence of some clusters of axons with the same small mean diameter and 
thinner myelin sheath (Figure 2G).
After these images sowing just few aspects of pathological degradation of 
peripheral nerve, focusing on myelin sheath damage, let’s take a closer look at what 
happens in the Schwann cell, at the cellular and molecular level.
3. Myelin protein gene expression in peripheral nerve after injury
Investigating the evolution of the main proteins that enter the composition of 
myelin sheath during and after nerve injury has been a subject of study for many 
Figure 4. 
Teased nerve fiber (sural nerve biopsy) panel. (A) A nerve fiber with segmental demyelination near two other 
normal myelinated fibers. (B) Near normal fibers, a fiber with segmental demyelination (a thin internode) 
and a fiber with few myelin ovoids and balls (axonal degeneration). (C) More myelin ovoids in an axonal 
degeneration. (D) A tomacula in myelin sheath of a nerve fiber.
Figure 5. 
Peripheral nerve remyelination. In demyelinating peripheral neuropathies, the segmental demyelination is 
often seen. Following a Schwann cell degeneration, the lost myelin internode is replaced by some Schwann cells 
which generate myelin sheaths, resulting in many shorter internodes.
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scientists. These proteins are P zero (P0), myelin basic protein (MPZ), and P2. 
The first two play an important role in maintaining the integrity and compactness 
of the myelin sheath. P2 is a lipid-binding protein and participates in fatty acid 
elongation and transport during the myelination process [7]. Myelin associated 
glycoprotein (MAG) is a transmembrane protein that is found in the periaxonal 
region and participates in SC-axon contact organization. It seems to be involved 
in the myelination process after injury [8]. P0 and MBP mRNA in the distal nerve 
portion after transection were found to be 20% lower than normal levels but have 
had normal levels after crushing [9, 10]. In the absence of a contact between SCs 
and the axon, the levels of mRNAs of P0 and MBP remained low, and mRNA of 
MAG was undetectable, long time after nerve transection, whereas MAG mRNA 
was undetectable after lesion; in the case of a crush injury, after a sudden and 
short decrease, the mRNA levels of these proteins were found to increase rapidly 
afterwards [10, 11].
4. Biological aspects of Schwann cell
To understand what plasticity of Schwann cells means, we need to understand 
what the starting point is for their differentiation and evolution.
4.1 Schwann cell differentiation and development
During development, SCs surround bundles of axons and support them to out-
grow by releasing growth factors such as nerve growth factor (NGF), glial cell line-
derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), 
and neurotrophin (NT3) [12–14]. It follows a “radial sorting” of axons by extension 
of cellular process from Schwann cells, which begins to divide axon bundles into 
smaller ones and finally separate the neighboring axons with cell cytoplasm. Thus 
two types of fibers are formed: (i) unmyelinated Remak fibers, in which SC sur-
rounds several small-sized axons (sensory and autonomic) and does not produce 
myelin, and (ii) myelinated fibers in which each large-sized axon is surrounded by 
a SC cell, 1:1 relationship, and a myelin sheath is formed by SC membrane spirally 
wrapping the axon [15]. Mesaxon is termed the point where the plasma membrane 
apposition is formed where the first encircling process meets itself. Remak SCs 
maintain the proliferative capacity of all the life [16].
During this stage, changes in cell morphology and gene expression occur, medi-
ated by the transcription factor Krox-20 (or Egr-2) [17–19].
4.2 Interactions between Schwann cells and axons
The differentiation of Schwann cells is controlled by some growth factors among 
which the most important are in the neuregulin family. Neuregulins (Nrgs) are trans-
membrane proteins that signal through ErbB tyrosine kinase receptors [20]. Axonal 
neuregulin-1 (Nrg1), produced in many isoforms by alternative splicing (heregulin, 
glial growth factor, sensory and motor neuron-derived factor), interacts with ErbB2/
ErbB3 receptors tyrosine kinase expressed on Schwann cells [21–25]. ErbB2 and 
ErbB3 combine to act as heterodimers and efficiently bind Nrg1. Nrg1/ErbB signal-
ing axis has a critical role in Schwann cell development (for review [26–28]) like 
survival, proliferation, migration, differentiation, and myelination [26, 29–32].
Nrgs need protease involvement for Nrg1-ErbB interactions because Nrgs are 
synthesized as single-pass transmembrane proteins and shed from the cell surface 
7Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury
DOI: http://dx.doi.org/10.5772/intechopen.91805
by the proteolytic cleavage, thus permitting the interaction with ErbB receptors 
across the periaxonal space [33, 34].
Another enzyme implicated in Nrg1 cleavage is beta-amyloid converting enzyme 
(BACE1), a beta-secretase present in axon [35, 36]. An in vivo study showed that 
the BACE1-null mice presented reduced rates of Nrg1 cleavage and decreased PNS 
myelin, a low capacity of myelination with axons with a thinner myelin sheath [35].
An effect opposite to the BACE activity has tumor necrosis factor-alpha-con-
verting enzyme (TACE), a neuronal alpha-secretase, cleaving Nrg1 into an inactive 
form [37]. TACE genetic inactivation in motor neurons caused hypermyelination 
like in Nrg1 overexpression.
Another factor that is essential in SCs-axon interaction, with a protection 
role for the axon, is Schwann cell basal lamina. The basal lamina together with 
extracellular collagen fibrils protects axons from extension and compression 
injuries. They provide good support for axonal outgrowth and guidance (reviewed 
by [38]). Basal lamina defines also Schwann cell orientation in axonal myelination 
[39]. More of this, SCs require axonal contact for secreting the components of 
basal lamina, so the relationship of axon-SCs via basal lamina is interactive and 
reciprocal [40, 41].
All these interactions described above are very important and may be modulated 
in the control of nerve regeneration.
5. Schwann cell plasticity
PNS has a very good regenerative capacity, and this is largely due to Schwann 
cells that develop a high plasticity and can contribute very quickly to the regen-
eration of peripheral nerves after injury whether it is a trauma or a pathological 
condition. In these cases, SCs have the ability to transform into an immature-like 
form, which drives subsequent regeneration of the nerve. These processes of 
dedifferentiation into non-myelinating cells and redifferentiation after injury are 
characteristic of these glial cells in PNS, and in the last decade a significant progress 
has been made in the study of the molecular mechanisms and signaling pathways 
that regulate this plasticity (reviewed in [42]). More of this, the myelinating and 
non-myelinating SCs remain bipotential cells all the time, as demonstrated by graft-
ing or nerve cross anastomosis experiments [43–45]. Many experimental studies 
on transgenic animals have shown that after nerve cut or crush, both types of SCs 
reprogram into proliferative progenitor-like repair SCs [46, 47]. This phenomenon 
involves downregulation of pro-myelinating genes, such as early growth response 
2 (Egr-2 or Krox-20), POU domain class 3 transcription factor 1 (Pou3f1 or Oct-
6), and myelin protein zero (MPZ)/myelin basic protein (MBP). There is also an 
upregulation of markers of dedifferentiated (immature) SCs like low affinity neu-
rotrophin receptor (p75NTR), c-Jun, or glial fibrillary acidic protein (GFAP) [6].
After Wallerian degeneration following nerve injury, a downregulation of pro-
myelinating genes occurs, and the myelin clearing phenomenon begins after myelin 
sheath disorganization, through a mechanism of autophagy or myelinophagy [48]. 
Macrophages also participate in this process, phagocytosing myelin and axonal 
debris. The recruitment of macrophages is also done by SCs [49–51].
One of the major problems of human SCs is that as their regenerative capacity 
decreases in time, they can no longer sustain axonal growth, and their numbers 
decrease greatly (reviewed in [52]).
Regarding the plasticity of Schwann cells, although not covered by this chapter, 
we just want to mention here that SC precursors can generate many and different 
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cell types during embryogenesis, besides myelinating and non-myelinating SCs, 
such as endoneurial fibroblasts, melanocytes, and neurons [52].
5.1 Schwann cell dedifferentiation
After injury, SCs reacquire some capabilities from early development, like pro-
liferation, production of growth factors, sorting, and myelination. A good review 
regarding the biology of Schwann cells is the one made by Kidd et al. [3].
SC behavior and fate is regulated by two sort of interactions: SCs-axon and SCs-
extracellular matrix/basal matrix. After 48 hours following axonal transection, SCs 
downregulate the production of myelin protein mRNAs [53] and upregulate trophic 
factors and cytokines [12–14] like NGF, BDNF, GDNF, and LIF, molecules necessary 
in axonal regeneration promoting into distal stump (reviewed in [54]). After axonal 
injury/transection, the axon is rapidly destroyed by a nonapoptotic autonomous 
mechanism [55]. SCs begin myelin degradation after axon injury, disassembling first 
the myelin internode starting with Schmidt-Lantermann incisure swelling [56, 57], 
following the dissolution of myelin in bubbles, ovoids, and balls. Macrophages finish 
the myelin degradation by phagocytosis [58]. It is not known exactly how much 
the SCs contribute to myelin degradation compared to macrophage participation, 
but it seems that it depends on the volume of the internode [59, 60]. During myelin 
degeneration, changes occur in the SC microtubule network, lysosome, and endo-
some positioning [61].
After nerve crush or transection, between the two stumps, over the lesion site, 
fibroblasts form a bridge, interacting with SCs [62]. The newly formed vasculature 
participates also in guiding the growing axons through this bridge to the distal end 
[63]. After a period of persistence of distal nerve stumps, distal axons disappear 
and dedifferentiated SCs proliferate, align, and begin emitting processes, forming 
the bands of Bungner (Figure 1), offering a physical and trophic support for the 
regrowth of axon [44, 60].
After the axonal regeneration, SCs differentiate once more in non-myelinating 
and myelinating cells to finish the functional recovery of the nerve. The regenerated 
myelin internodes (Figure 5) are shorter and thinner than the rest of the original 
ones in the proximal part of nerve [64].
5.2 Molecular mechanisms which control SC plasticity
The molecular mechanisms that regulate SC plasticity are very complex and 
widely described in many studies in recent years (reviewed in [42]). Here we will 
briefly mention them.
5.2.1 Transcriptional factors
One important transcriptional factor in SC reprogramming is c-Jun. Although it 
is downregulated or absent in the differentiation of SC, under pathological condi-
tions c-Jun is particularly upregulated as described in various peripheral neuropa-
thies [65–69], being a cross-antagonist of Krox-20 (a pro-myelinating transcription 
factor). c-Jun take part at the myelinophagy process [47] and participate also in the 
macrophage recruitment following nerve injury [70].
Another transcriptional regulator is NICD, an intracellular domain generated 
from neurogenic locus notch homolog protein (Notch) cleavage. SC proliferation 
and generation of immature SCs are controlled by Notch. But the same Notch is a 
negative regulator of myelination [71].
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Nuclear factor kB (NF-kB), a transcription factor which regulates many physi-
ological processes especially the inflammatory response, is very important for SC 
differentiation and myelination as in vitro studies showed [72–74].
In the recent years, a transcriptional repressor, Zeb2, has been investigated, and 
the researchers showed that it is implied in SC differentiation and myelination. The 
lack of Zeb2 in SCs results in a failure of SC maturation and in absence of myelin 
membranes [75].
Other factors which are overexpressed in SC dedifferentiation are Sox-2, paired 
box protein 3 (Pax-3), early growth response proteins 1 and 3 (Egr-1 and Egr-3), 
and DNA-binding protein inhibitor 2 (Id2) [66, 76, 77]. Sox-2 is also necessary for 
the nerve bridge formation after nerve injury [62].
mTOR complex 1 (mTORC1) (reviewed in [78]) has a significant role on the 
transcriptome by controlling transcription factors [79–82]. It promotes anabo-
lism, counting mRNA translation, and purine and pyrimidine synthesis [83, 84]. 
mTORC1 is necessary in radial sorting of axons by SCs, biosynthesis of lipids, 
and, on this basis, myelin growth [85, 86]. The mTORC1 activity is higher before 
myelination onset and decreases when myelination starts [87–89].
5.2.2 Mitogen-activated protein kinase (MAPK) family proteins
In the distal stump of the peripheral nerve after injury SCs respond by activating 
MAPK proteins like extracellular signal-regulated kinase (Erk), c-Jun N-terminal 
kinase (JNK), and p38 MAP kinase [66, 90–95].
Ras/Raf/Erk signaling in SC dedifferentiation was studied for the first time by 
Harrisingh et al., and they showed that the Raf activation suppresses the differen-
tiation of primary SCs induced by cyclic adenosine monophosphate (cAMP) [91]. 
Raf is an activator of Erk. The authors demonstrated that the activation of Ras/Raf/
Erk pathway induced demyelination in an in vitro study on cocultured cells—SCs 
and neurons from dorsal root ganglia.
Erk activation is a pro-myelinating factor, and if Erk is inhibited, the SC differ-
entiation and myelination are blocked, showed many in vivo studies [96–98].
In conclusion, Erk signaling is required in differentiation (Erk low levels) but 
also in dedifferentiation (high Erk levels) of SCs after nerve lesion [99, 100].
JNK, another MAPK protein, is implied in SC functions, so when c-Jun is acti-
vated by JNK, the migration and proliferation of SCs are produced [19, 101, 102].
Without insisting, we would like just to remember other MAPK proteins and 
signaling pathways involved in SC plasticity: p38MAPK, PI3K/Akt/mTOR signal-
ing (reviewed by [42]).
5.2.3 TLRs signaling
After nerve injury, inflammation is an important phenomenon that must be con-
sidered. Thus, Toll-like receptors (TLRs) are key factors in initiating the immune 
response. A number of such receptors are expressed by SCs: TLR3, TLR4, and TLR7 
[103]. Some experimental studies showed an upregulation of TLRs following nerve 
injury, the effect being the inflammation trigger with macrophage recruitment and 
activation and myelin clearance via SCs [50, 104, 105].
5.2.4 Nrg1/ErbB2/3 signaling
SCs express receptors for axonal neuregulins, as it is showed in Ssection 
2.2. The neuregulin/Erb2/3 signaling is strongly involved in immature SC 
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development but not in the regulation of adult SC proliferation after injury. An 
in vivo study on erbB2 wt/lacZ (with highly reduced ErbB2 levels in adult sciatic 
nerves) mice showed that after sciatic nerve transection, SC proliferation is not 
affected in adult ErbB2-conditional null nerves. More of this, the maintenance of 
myelinated peripheral nerves did not require ErbB2 function [106]. Other stud-
ies demonstrated that ErbB2 activation after sciatic nerve axotomy induced SC 
demyelination [107].
Neuregulin Nrg1 is still necessary for adult SC evolution after nerve injury 
[108, 109]. The absence of Nrg1 in adult axons results in remyelination defects 
after nerve crush experiments and also in a slower axon regeneration [110].
6. Therapeutical approaches based on Schwann cell plasticity
Although the peripheral nerve has a much greater regenerative capacity than the 
CNS nerve, the clinical recovery of patients with peripheral neuropathies is dif-
ficult, slow and often incomplete. Moreover, this capacity decreases with age.
The rate of nerve regeneration is approximately 1 mm/day, depending on the site 
of the lesion and on the patient age. SC plasticity diminishes with age, showing an 
altered expression of c-Jun [111] and a weak regenerative capacity [112, 113].
Understanding the signaling pathways that govern SC reprogramming and 
plasticity is essential for nerve repair and therapy.
For example, modulating Nrg1/ErbB signaling may improve myelin clearance, 
axonal regeneration, and finally functional nerve recovery after injury. An inap-
propriate overactivation of this pathway may lead to demyelinating neuropathies 
or tumors like neuroepithelioma and neuroplastic SC line [114, 115]. Experiments 
on transgenic mice with overexpression of Nrg1 showed hypertrophic neuropathies 
and malignant peripheral nerve sheath tumors [116]. The excessive activation 
of ErbB2 by Mycobacterium leprae determines one of the symptoms of leprosy, 
an important peripheral nerve demyelination [117]. In Charcot-Marie-Tooth 1A, 
abnormal demyelination and axon loss were prevented by Nrg1 therapy during early 
postnatal period in a rat model [118].
Another approach to stimulate SC regeneration and peripheral nerve functional 
recovery is the exogenous modulation by electric stimulation with low frequencies, 
photomodulation with low-level laser, and pharmacotherapy (with pharmacological 
agents, growth factors, bioproducts, or hormones) (reviewed by [119]).
7. Conclusions
Understanding Schwann cell biology and its extraordinary plasticity can lead to 
the development of new therapeutic approaches in peripheral nerve pathology and 
in the improvement of treatment methods in the case of traumatic nerve lesions. 
Peripheral neuropathies cause a significant morbidity and a decreased life quality. A 
better understanding of the many SC signaling pathways represents a very impor-
tant approach for nerve regeneration as long as we have seen that SC is the main 
engine in nerve damage and repair after injury.
The recovery of the peripheral nerve, although better than that of the CNS 
nerve, is still quite complicated, difficult many times, and it is never perfect until 
the end. But in the last years, a huge amount of scientific data drew attention to the 
role of growth factors, transcriptional factors, inflammatory factors, hormones, 
and even exogenous modulation factors in the regulation of Schwann cell and of 
Schwann cell-axon interrelations, a complex integrated system.
11
Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury
DOI: http://dx.doi.org/10.5772/intechopen.91805
Author details
Emilia Manole1,2*, Alexandra Eugenia Bastian2,3, Ana Maria Oproiu3,4,  
Monica Teodora Neagu1,2, Carolina Constantin1,2 and Gheorghita Isvoranu1
1 “Victor Babes” National Institute of Pathology, Bucharest, Romania
2 Colentina Clinical Hospital, Bucharest, Romania
3 “Carol Davila” Faculty of Medicine, Bucharest, Romania
4 Emergency University Hospital, Bucharest, Romania
*Address all correspondence to: emilia_manole@yahoo.com
It is expected that studies regarding SCs plasticity in peripheral nerve regenera-
tion will continue and expand, improving not only the scientific knowledge but also 
a targeted more effective therapies, based on the pathology, personalized treatment 
and specific response of patients.
Acknowledgements
This work was supported by the Ministry of Education and Research in 
Romania, under the following grants: Program 1, The improvement of the 
National System of Research and Development and Subprogram 1.2—Institutional 
Excellence—Projects of Excellence Funding in RDI, Contract nr. 7PFE/16.10.2018; 
PN 19.29.02.01; by UEFISCDI, grant, Project PN-III-P1-1.2-PCCDI-2017-0782 
(REGMED); and by COST 18125 AeroGels.
Conflict of interest
The authors declare no conflict of interest.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
12
Schwann Cells
[1] Schwann TH. Microscopical 
Researches into the Accordance in 
the Structure and Growth of Animals 
and Plants. Vol. 1. London: Sydenham 
Society; 1847. DOI: 10.1002/j.1550-
8528.1993.tb00021.x
[2] Ramón Y, Cajal S, DeFelipe J, 
Jones EG, May RM. Cajal’s Degeneration 
and Regeneration of the Nervous 
System. Oxford, England: Clarendon 
Press; 2012. DOI: 10.1093/acprof:
oso/9780195065169.001.0001
[3] Kidd GJ, Ohno N, Trapp BD.  
Biology of Schwann cells. In: Said G  
and Krarup C, editors. Handbook 
of Clinical Neurology. 1st ed. Vol. 
115. Amsterdam: Elsevier B.V. 
2013. pp. 55-79. DOI: 10.1016/
B978-0-444-52902-2.00005-9
[4] Brennan A, Dean CH, Zhang 
AL, Cass DT, Mirsky R, Jessen KR. 
Endothelins control the timing of 
Schwann cell generation in vitro 
and in vivo. Developmental Biology. 
2000;227(2):545-557. DOI: 10.1006/
dbio.2000.9887
[5] Wakamatsu Y, Maynard TM, 
Weston JA. Fate determination of 
neural crest cells by NOTCH-mediated 
lateral inhibition and asymmetrical 
cell division during gangliogenesis. 
Development. 2000;127(13):2811-2821
[6] Jessen KR, Mirsky R. Negative 
regulation of myelination: Relevance for 
development, injury, and demyelinating 
disease. Glia. 2008;56(14):1552-1565. 
DOI: 10.1002/glia.20761
[7] Narayanan V, Barbosa E, Reed R, 
Tennekoon G. Characterization of a 
cloned cDNA encoding rabbit myelin 
P2 protein. The Journal of Biological 
Chemistry. 1988;263(17):8332-8337
[8] Quarles RH. Myelin-associated 
glycoprotein in development 
and disease. Developmental 
Neuroscience. 1983;6(6):285-303. DOI: 
10.1159/000112356
[9] Leblanc AC, Poduslo JF, Mezei C. 
Gene expression in the presence or 
absence of myelin assembly. Molecular 
Brain Research. 1987;2(1):57-67. DOI: 
10.1016/0169-328X(87)90021-0
[10] Gupta SK, Poduslo JF, Mezei C. 
Temporal changes in PO and MBP gene 
expression after crush-injury of the 
adult peripheral nerve. Molecular Brain 
Research. 1988;4(2):133-141. DOI: 
10.1016/0169-328X(88)90005-8
[11] LeBlanc AC, Poduslo JF. Axonal 
modulation of myelin gene expression 
in the peripheral nerve. Journal of 
Neuroscience Research. 1990;26(3):317-
326. DOI: 10.1002/jnr.490260308
[12] Meyer M, Matsuoka I,  
Wetmore C, Olson L, Thoenen H. 
Enhanced synthesis of brain-derived 
neurotrophic factor in the lesioned 
peripheral nerve: Different mechanisms 
are responsible for the regulation of 
BDNF and NGF mRNA. The Journal of 
Cell Biology. 1992;119(1):45-54. DOI: 
10.1083/jcb.119.1.45
[13] Curtis R, Scherer SS, Somogyi R, 
et al. Retrograde axonal transport of 
LIF is increased by peripheral nerve 
injury: Correlation with increased 
LIF expression in distal nerve. 
Neuron. 1994;12(1):191-204. DOI: 
10.1016/0896-6273(94)90163-5
[14] Höke A, Redett R, Hameed H, et al. 
Schwann cells express motor  
and sensory phenotypes that regulate 
axon regeneration. The Journal  
of Neuroscience. 2006;26(38): 
9646-9655. DOI: 10.1523/
JNEUROSCI.1620-06.2006
[15] Webster HDF. The geometry of 
peripheral myelin sheaths during their 
formation and growth in rat sciatic 
References
13
Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury
DOI: http://dx.doi.org/10.5772/intechopen.91805
nerves. The Journal of Cell Biology. 
1971;48(2):348-367. DOI: 10.1083/
jcb.48.2.348
[16] Murinson BB, Archer DR, Li Y, 
Griffin JW. Degeneration of myelinated 
efferent fibers prompts mitosis in 
Remak Schwann cells of uninjured 
C-fiber afferents. The Journal of 
Neuroscience. 2005;25(5):1179-1187. 
DOI: 10.1523/JNEUROSCI.1372-04.2005
[17] Topilko P, Schneider-Maunoury S, 
Levi G, et al. Krox-20 controls 
myelination in the peripheral nervous 
system. Nature. 1994;371(6500): 
796-799. DOI: 10.1038/371796a0
[18] Nagarajan R, Svaren J, Le N, 
Araki T, Watson M, Milbrandt J. EGR2 
mutations in inherited neuropathies 
dominant-negatively inhibit 
myelin gene expression. Neuron. 
2001;30(2):355-368. DOI: 10.1016/
S0896-6273(01)00282-3
[19] Parkinson DB, Bhaskaran A, 
Droggiti A, et al. Krox-20 inhibits 
Jun-NH2-terminal kinase/c-Jun to 
control Schwann cell proliferation and 
death. The Journal of Cell Biology. 
2004;164(3):385-394. DOI: 10.1083/
jcb.200307132
[20] Falls DL. Neuregulins: Functions, 
forms, and signaling strategies. 
Experimental Cell Research. 
2003;284(1):14-30. DOI: 10.1016/
S0014-4827(02)00102-7
[21] Cohen JA, Yachnis AT, Arai M, 
Davis JG, Scherer SS. Expression of the 
neu proto-oncogene by schwann cells 
during peripheral nerve development 
and wallerian degeneration. Journal of 
Neuroscience Research. 1992;31(4): 
622-634. DOI: 10.1002/jnr.490310406
[22] Ho WH, Armanini MP, Nuijens A, 
Phillips HS, Osheroff PL. Sensory and 
motor neuron-derived factor. A novel 
heregulin variant highly expressed 
in sensory and motor neurons. The 
Journal of Biological Chemistry. 
1995;270(24):14523-14532. DOI: 
10.1074/jbc.270.24.14523
[23] Levi ADO, Bunge RP, Lofgren JA, 
et al. The influence of heregulins on 
human Schwann cell proliferation. 
The Journal of Neuroscience. 
1995;15(2):1329-1340. DOI: 10.1523/
jneurosci.15-02-01329.1995
[24] Carroll SL, Miller ML, 
Frohnert PW, Kim SS, Corbett JA. 
Expression of neuregulins and their 
putative receptors, ErbB2 and ErbB3, is 
induced during Wallerian degeneration. 
The Journal of Neuroscience. 
1997;17(5):1642-1659. DOI: 10.1523/
jneurosci.17-05-01642.1997
[25] Vartanian T, Goodearl A, Viehöver A, 
Fischbach G. Axonal neuregulin signals 
cells of the oligodendrocyte lineage 
through activation of HER4 and 
Schwann cells through HER2 and 
HER3. The Journal of Cell Biology. 
1997;137(1):211-220. DOI: 10.1083/
jcb.137.1.211
[26] Newbern J, Birchmeier C. Nrg1/
ErbB signaling networks in Schwann 
cell development and myelination. 
Seminars in Cell & Developmental 
Biology. 2010;21(9):922-928. DOI: 
10.1016/j.semcdb.2010.08.008
[27] Grigoryan T, Birchmeier W. 
Molecular signaling mechanisms 
of axon-glia communication in the 
peripheral nervous system. BioEssays. 
2015;37(5):502-513. DOI: 10.1002/
bies.201400172
[28] Willem M. Proteolytic processing of 
Neuregulin-1. Brain Research Bulletin. 
2016;126:178-182. DOI: 10.1016/j.
brainresbull.2016.07.003
[29] Syroid DE, Maycox PR, Burrola PG, 
et al. Cell death in the Schwann cell 
lineage and its regulation by neuregulin. 
Proceedings of the National Academy 
Schwann Cells
14
of Sciences of the United States of 
America. 1996;93(17):9229-9234. DOI: 
10.1073/pnas.93.17.9229
[30] Leimeroth R, Lobsiger C, 
Lüssi A, Taylor V, Suter U, Sommer L. 
Membrane-bound neuregulin1 type 
III actively promotes Schwann 
cell differentiation of multipotent 
progenitor cells. Developmental Biology. 
2002;246(2):245-258. DOI: 10.1006/
dbio.2002.0670
[31] Taveggia C, Zanazzi G, Petrylak A, 
et al. Neuregulin-1 type III determines 
the ensheathment fate of axons. 
Neuron. 2005;47(5):681-694. DOI: 
10.1016/j.neuron.2005.08.017
[32] Chen S, Velardez MO, Warot X, 
et al. Neuregulin 1-erbB signaling 
is necessary for normal myelination 
and sensory function. The Journal of 
Neuroscience. 2006;26(12):3079-3086. 
DOI: 10.1523/JNEUROSCI.3785-05.2006
[33] Kalderon N. Migration of Schwann 
cells and wrapping of neurites in 
vitro: A function of protease activity 
(plasmin) in the growth medium. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 1979;76(11):5992-5996. DOI: 
10.1073/pnas.76.11.5992
[34] Baron-Van Evercooren A,  
Leprince P, Rogister B, et al. 
Plasminogen activators in developing 
peripheral nervous system, 
cellular origin and mitogenic 
effect. Developmental Brain 
Research. 1987;36(1):101-108. DOI: 
10.1016/0165-3806(87)90068-X
[35] Hu X, Hicks CW, He W, et al. Bace1 
modulates myelination in the central 
and peripheral nervous system. Nature 
Neuroscience. 2006;9(12):1520-1525. 
DOI: 10.1038/nn1797
[36] Willem M, Garratt AN, 
Novak B, et al. Control of peripheral 
nerve myelination by the β-secretase 
BACE1. Science (80-). 2006;314(5799): 
664-666. DOI: 10.1126/science.1132341
[37] La Marca R, Cerri F, Horiuchi K,  
et al. TACE (ADAM17) inhibits Schwann 
cell myelination. Nature Neuroscience. 
2011;14(7):857-865. DOI: 10.1038/
nn.2849
[38] Bunge MB, Bunge RP, Kleitman N, 
Dean AC. Role of peripheral nerve 
extracellular matrix in schwann cell 
function and in neurite regeneration. 
Developmental Neuroscience. 
1989;11(4-5):348-360. DOI: 
10.1159/000111911
[39] Bunge MB, Williams AK, Wood PM. 
Neuron-schwann cell interaction in 
basal lamina formation. Developmental 
Biology. 1982;92(2):449-460. DOI: 
10.1016/0012-1606(82)90190-7
[40] Carey DJ, Eldridge CF, 
Cornbrooks CJ, Timpl R, Bunge RP. 
Biosynthesis of type IV collagen by 
cultured rat Schwann cells. The Journal 
of Cell Biology. 1983;97(2):473-479. 
DOI: 10.1083/jcb.97.2.473
[41] Carey DJ, Todd MS. Schwann 
cell myelination in a chemically 
defined medium: Demonstration 
of a requirement for additives that 
promote Schwann cell extracellular 
matrix formation. Developmental Brain 
Research. 1987;32(1):95-102. DOI: 
10.1016/0165-3806(87)90142-8
[42] Boerboom A, Dion V, Chariot A, 
Franzen R. Molecular mechanisms 
involved in schwann cell plasticity. 
Frontiers in Molecular Neuroscience. 
2017;10(February):1-18. DOI: 10.3389/
fnmol.2017.00038
[43] Simpson SA, Young JZ. 
Regeneration of fibre diameter after 
cross-unions of visceral and 
somatic nerves. Journal of Anatomy. 
1945;79(Pt 2):48-65
[44] Weinberg HJ, Spencer PS. Studies 
on the control of myelinogenesis. I. 
15
Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury
DOI: http://dx.doi.org/10.5772/intechopen.91805
Myelination of regenerating axons 
after entry into a foreign unmyelinated 
nerve. Journal of Neurocytology. 
1975;4(4):395-418. DOI: 10.1007/
BF01261372
[45] Aguayo AJ, Epps J, Charron L, 
Bray GM. Multipotentiality of Schwann 
cells in cross-anastomosed and 
grafted myelinated and unmyelinated 
nerves: Quantitative microscopy 
and radioautography. Brain 
Research. 1976;104(1):1-20. DOI: 
10.1016/0006-8993(76)90643-0
[46] Chen Z-L, Yu W-M, Strickland S. 
Peripheral regeneration. Annual Review 
of Neuroscience. 2007;30(1): 
209-233. DOI: 10.1146/annurev.
neuro.30.051606.094337
[47] Jessen KR, Mirsky R. The repair 
Schwann cell and its function in 
regenerating nerves. The Journal of 
Physiology. 2016;594(13):3521-3531. 
DOI: 10.1113/JP270874
[48] Gomez-Sanchez JA, Carty L, 
Iruarrizaga-Lejarreta M, et al. Schwann 
cell autophagy, myelinophagy, 
initiates myelin clearance from injured 
nerves. The Journal of Cell Biology. 
2015;210(1):153-168. DOI: 10.1083/
jcb.201503019
[49] Hirata K, Kawabuchi M. Myelin 
phagocytosis by macrophages and 
nonmacrophages during Wallerian 
degeneration. Microscopy Research and 
Technique. 2002;57(6):541-547. DOI: 
10.1002/jemt.10108
[50] Lee H, Jo EK, Choi SY, et al. Necrotic 
neuronal cells induce inflammatory 
Schwann cell activation via TLR2 
and TLR3: Implication in Wallerian 
degeneration. Biochemical and 
Biophysical Research Communications. 
2006;350(3):742-747. DOI: 10.1016/j.
bbrc.2006.09.108
[51] Barrette B, Hébert MA, Filali M, 
et al. Requirement of myeloid cells 
for axon regeneration. The Journal of 
Neuroscience. 2008;28(38):9363-9376. 
DOI: 10.1523/JNEUROSCI.1447-08.2008
[52] Jessen KR, Mirsky R. The success 
and failure of the schwann cell response 
to nerve injury. Frontiers in Cellular 
Neuroscience. 2019;13:1-14. DOI: 
10.3389/fncel.2019.00033
[53] Lemke G, Chao M. Axons regulate 
Schwann cell expression of the major 
myelin and NGF receptor genes. 
Development. 1988;102(3):499-504
[54] Terenghi G. Peripheral nerve 
regeneration and neurotrophic factors. 
Journal of Anatomy. 1999;194(1):1-14. 
DOI: 10.1017/S0021878298004312
[55] Saxena S, Caroni P. Mechanisms of 
axon degeneration: From development 
to disease. Progress in Neurobiology. 
2007;83(3):174-191. DOI: 10.1016/j.
pneurobio.2007.07.007
[56] Ghabriel MN, Allt G. The role 
of Schmidt-Lanterman incisures 
in Wallerian degeneration—II. An 
electron microscopic study. Acta 
Neuropathologica. 1979;48(2):95-103. 
DOI: 10.1007/BF00691150
[57] Ghabriel MN, Allt G. Incisures 
of Schmidt-Lanterman. Progress in 
Neurobiology. 1981;17(1-2):25-58. DOI: 
10.1016/0301-0082(81)90003-4
[58] Stoll G, Griffin JW, Li CY, Trapp BD. 
Wallerian degeneration in the peripheral 
nervous system: Participation of 
both Schwann cells and macrophages 
in myelin degradation. Journal of 
Neurocytology. 1989;18(5):671-683. 
DOI: 10.1007/BF01187086
[59] Beuche W, Friede RL. The role 
of non-resident cells in Wallerian 
degeneration. Journal of Neurocytology. 
1984;13(5):767-796. DOI: 10.1007/
BF01148493
[60] Stoll G, Müller HW. Nerve injury, 
axonal degeneration and neural 
Schwann Cells
16
regeneration: Basic insights. Brain 
Pathology. 2006;9(2):313-325. DOI: 
10.1111/j.1750-3639.1999.tb00229.x
[61] Kidd G, Andrews SB, Trapp BD. 
Axons regulate the distribution of 
Schwann cell microtubules. 
The Journal of Neuroscience. 
1996;16(3):946-954. DOI: 10.1523/
jneurosci.16-03-00946.1996
[62] Parrinello S, Napoli I, Ribeiro S, 
et al. EphB signaling directs peripheral 
nerve regeneration through Sox2-
dependent Schwann cell sorting. Cell. 
2010;143(1):145-155. DOI: 10.1016/j.
cell.2010.08.039
[63] Cattin AL, Burden JJ, Van 
Emmenis L, et al. Macrophage-induced 
blood vessels guide Schwann cell-
mediated regeneration of peripheral 
nerves. Cell. 2015;162(5):1127-1139. 
DOI: 10.1016/j.cell.2015.07.021
[64] Schröder JM. Altered ratio between 
axon diameter and myelin sheath 
thickness in regenerated nerve fibers. 
Brain Research. 1972;45(1):49-65. DOI: 
10.1016/0006-8993(72)90215-6
[65] Stewart HJS. Expression of c-Jun, 
Jun B, Jun D and cAMP response 
element binding protein by schwann 
cells and their precursors in vivo and 
in vitro. The European Journal of 
Neuroscience. 1995;7(6):1366-1375. 
DOI: 10.1111/j.1460-9568.1995.tb01128.x
[66] Parkinson DB, Bhaskaran A, 
Arthur-Farraj P, et al. c-Jun is a negative 
regulator of myelination. The Journal of 
Cell Biology. 2008;181(4):625-637. DOI: 
10.1083/jcb.200803013
[67] Hutton EJ, Carty L, Laurá M, 
et al. C-Jun expression in human 
neuropathies: A pilot study. Journal 
of the Peripheral Nervous 
System. 2011;16(4):295-303. DOI: 
10.1111/j.1529-8027.2011.00360.x
[68] Hantke J, Carty L, Wagstaff LJ, 
et al. c-Jun activation in Schwann 
cells protects against loss of sensory 
axons in inherited neuropathy. Brain. 
2014;137(11):2922-2937. DOI: 10.1093/
brain/awu257
[69] Klein D, Groh J, Wettmarshausen J, 
Martini R. Nonuniform molecular 
features of myelinating Schwann 
cells in models for CMT1: Distinct 
disease patterns are associated with 
NCAM and c-Jun upregulation. Glia. 
2014;62(5):736-750. DOI: 10.1002/
glia.22638
[70] Arthur-Farraj PJ, Latouche M, 
Wilton DK, et al. c-Jun reprograms 
schwann cells of injured nerves to 
generate a repair cell essential for 
regeneration. Neuron. 2012;75(4): 
633-647. DOI: 10.1016/j.
neuron.2012.06.021
[71] Woodhoo A, Alonso MBD, 
Droggiti A, et al. Notch controls 
embryonic Schwann cell differentiation, 
postnatal myelination and adult plasticity. 
Nature Neuroscience. 2009;12(7): 
839-847. DOI: 10.1038/nn.2323
[72] Nickols JC, Valentine W, 
Kanwal S, Carter BD. Activation of the 
transcription factor NF-κB in Schwann 
cells is required for peripheral myelin 
formation. Nature Neuroscience. 
2003;6(2):161-167. DOI: 10.1038/nn995
[73] Yoon C, Korade Z, 
Carter BD. Protein kinase A-induced 
phosphorylation of the p65 subunit 
of nuclear factor-κB promotes 
Schwann cell differentiation into a 
myelinating phenotype. The Journal of 
Neuroscience. 2008;28(14):3738-3746. 
DOI: 10.1523/JNEUROSCI.4439-07.2008
[74] Limpert AS, Carter BD. Axonal 
neuregulin 1 type III activates NF-κB in 
Schwann cells during myelin formation. 
The Journal of Biological Chemistry. 
2010;285(22):16614-16622. DOI: 
10.1074/jbc.M109.098780
[75] Quintes S, Brinkmann BG, Ebert M, 
et al. Zeb2 is essential for Schwann 
17
Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury
DOI: http://dx.doi.org/10.5772/intechopen.91805
cell differentiation, myelination and 
nerve repair. Nature Neuroscience. 
2016;19(8):1050-1059. DOI: 10.1038/
nn.4321
[76] Doddrell RDS, Dun XP, 
Moate RM, Jessen KR, Mirsky R, 
Parkinson DB. Regulation of Schwann 
cell differentiation and proliferation 
by the Pax-3 transcription factor. Glia. 
2012;60(9):1269-1278. DOI: 10.1002/
glia.22346
[77] Gao X, Daugherty RL, 
Tourtellotte WG. Regulation of low 
affinity neurotrophin receptor (p75NTR) 
by early growth response (Egr) 
transcriptional regulators. Molecular 
and Cellular Neurosciences. 
2007;36(4):501-514. DOI: 10.1016/j.
mcn.2007.08.013
[78] Norrmén C, Figlia G, Pfistner P, 
Pereira JA, Bachofner S, Suter U. 
mTORC1 is transiently reactivated 
in injured nerves to promote 
c-Jun elevation and schwann cell 
dedifferentiation. The Journal of 
Neuroscience. 2018;38(20): 
4811-4828. DOI: 10.1523/
JNEUROSCI.3619-17.2018
[79] Laughner E, Taghavi P, Chiles K, 
Mahon PC, Semenza GL. HER2 (neu) 
signaling increases the rate of 
hypoxia-inducible factor 1 (HIF-1)  
synthesis: Novel mechanism 
for HIF-1-mediated vascular 
endothelial growth factor expression. 
Molecular and Cellular Biology. 
2001;21(12):3995-4004. DOI: 10.1128/
mcb.21.12.3995-4004.2001
[80] Roczniak-Ferguson A, Petit CS, 
Froehlich F, et al. The transcription 
factor TFEB links mTORC1 signaling 
to transcriptional control of lysosome 
homeostasis. Science Signaling. 
2012;5(228):ra42. DOI: 10.1126/
scisignal.2002790
[81] Tiebe M, Lutz M, De La Garza A, 
Buechling T, Boutros M, Teleman AA. 
REPTOR and REPTOR-BP regulate 
organismal metabolism and 
transcription downstream of TORC1. 
Developmental Cell. 2015;33(3):272-
284. DOI: 10.1016/j.devcel.2015.03.013
[82] Park Y, Reyna-Neyra A, Philippe L, 
Thoreen CC. mTORC1 balances cellular 
amino acid supply with demand 
for protein synthesis through post-
transcriptional control of ATF4. Cell 
Reports. 2017;19(6):1083-1090. DOI: 
10.1016/j.celrep.2017.04.042
[83] Ben-Sahra I, Manning BD. mTORC1 
signaling and the metabolic control of 
cell growth. Current Opinion in Cell 
Biology. 2017;45:72-82. DOI: 10.1016/j.
ceb.2017.02.012
[84] Saxton RA, Sabatini DM. mTOR 
signaling in growth, metabolism, and 
disease. Cell. 2017;168(6):960-976. DOI: 
10.1016/j.cell.2017.02.004
[85] Sherman DL, Krols M, Wu LMN, et 
al. Arrest of myelination and reduced 
axon growth when Schwann cells lack 
mTOR. The Journal of Neuroscience. 
2012;32(5):1817-1825. DOI: 10.1523/
JNEUROSCI.4814-11.2012
[86] Norrmén C, Figlia G, 
Lebrun-Julien F, et al. mTORC1 controls 
PNS myelination along the mTORC1-
RXRγ-SREBP-lipid biosynthesis 
axis in Schwann cells. Cell Reports. 
2014;9(2):646-660. DOI: 10.1016/j.
celrep.2014.09.001
[87] Beirowski B, Wong KM, 
Babetto E, Milbrandt J. MTORC1 
promotes proliferation of immature 
Schwann cells and myelin growth 
of differentiated Schwann cells. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2017;114(21):E4261-E4270. 
DOI: 10.1073/pnas.1620761114
[88] Figlia G, Norrmén C, Pereira JA, 
Gerber D, Suter U. Dual function of the 
PI3K-Akt-MTORC1 axis in myelination 
Schwann Cells
18
of the peripheral nervous system. 
eLife. 2017;6:e29241. DOI: 10.7554/
eLife.29241
[89] Figlia G, Gerber D, Suter U. 
Myelination and mTOR. Glia. 
2018;66(4):693-707. DOI: 10.1002/
glia.23273
[90] Sheu JY, Kulhanek DJ, 
Eckenstein FP. Differential patterns 
of ERK and STAT3 phosphorylation 
after sciatic nerve transection in 
the rat. Experimental Neurology. 
2000;166(2):392-402. DOI: 10.1006/
exnr.2000.7508
[91] Harrisingh MC, Perez-Nadales E, 
Parkinson DB, Malcolm DS, Mudge AW, 
Lloyd AC. The Ras/Raf/ERK signalling 
pathway drives Schwann cell 
dedifferentiation. The EMBO Journal. 
2004;23(15):3061-3071. DOI: 10.1038/
sj.emboj.7600309
[92] Zrouri H, Le Goascogne C, Li WW, 
Pierre M, Courtin F. The role of MAP 
kinases in rapid gene induction after 
lesioning of the rat sciatic nerve. The 
European Journal of Neuroscience. 
2004;20(7):1811-1818. DOI: 
10.1111/j.1460-9568.2004.03641.x
[93] Agthong S, Kaewsema A, 
Tanomsridejchai N, Chentanez V. 
Activation of MAPK ERK in peripheral 
nerve after injury. BMC Neuroscience. 
2006;7:45. DOI: 10.1186/1471-2202-7-45
[94] Lee HJ, Shin YK, Park HT. Mitogen 
activated protein kinase family proteins 
and c-jun signaling in injury-induced 
schwann cell plasticity. Experimental 
Neurobiology. 2014;23(2):130. DOI: 
10.5607/en.2014.23.2.130
[95] Ronchi G, Haastert-Talini K, 
Fornasari BE, Perroteau I, Geuna S, 
Gambarotta G. The Neuregulin1/ErbB 
system is selectively regulated during 
peripheral nerve degeneration and 
regeneration. The European Journal of 
Neuroscience. 2016;43(3):351-364. DOI: 
10.1111/ejn.12974
[96] Grossmann KS, Wende H, Paul FE, 
et al. The tyrosine phosphatase Shp2 
(PTPN11) directs neuregulin-1/
ErbB signaling throughout Schwann 
cell development. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2009;106(39):16704-16709. DOI: 
10.1073/pnas.0904336106
[97] He Y, Kim JY, Dupree J, et al. Yy1 as 
a molecular link between neuregulin 
and transcriptional modulation 
of peripheral myelination. Nature 
Neuroscience. 2010;13(12):1472-1482. 
DOI: 10.1038/nn.2686
[98] Newbern JM, Li X, Shoemaker SE, 
et al. Specific functions for ERK/MAPK 
signaling during PNS development. 
Neuron. 2011;69(1):91-105. DOI: 
10.1016/j.neuron.2010.12.003
[99] Napoli I, Noon LA, Ribeiro S, et 
al. A central role for the ERK-signaling 
pathway in controlling schwann 
cell plasticity and peripheral nerve 
regeneration in vivo. Neuron. 
2012;73(4):729-742. DOI: 10.1016/j.
neuron.2011.11.031
[100] Newbern JM, Snider WD. 
Bers-ERK Schwann cells coordinate 
nerve regeneration. Neuron. 
2012;73(4):623-626. DOI: 10.1016/j.
neuron.2012.02.002
[101] Parkinson DB, Dong Z, Bunting H, 
et al. Transforming growth factor β 
(TGFβ) mediates Schwann cell death 
in vitro and in vivo: Examination 
of c-Jun activation, interactions 
with survival signals, and the 
relationship of TGFβ-mediated death 
to Schwann cell differentiation. 
The Journal of Neuroscience. 
2001;21(21):8572-8585. DOI: 10.1523/
jneurosci.21-21-08572.2001
[102] Yamauchi J, Chan JR, Shooter EM. 
Neurotrophin 3 activation of TrkC 
induces Schwann cell migration through 
the c-Jun N-terminal kinase pathway. 
Proceedings of the National Academy 
19
Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury
DOI: http://dx.doi.org/10.5772/intechopen.91805
of Sciences of the United States of 
America. 2003;100(SUPPL. 2):14421-
14426. DOI: 10.1073/pnas.2336152100
[103] Thakur KK, Saini J, Mahajan K,  
et al. Therapeutic implications of  
toll-like receptors in peripheral 
neuropathic pain. Pharmacological 
Research. 2017;115:224-232. DOI: 
10.1016/j.phrs.2016.11.019
[104] Goethals S, Ydens E, 
Timmerman V, Janssens S. Toll-like 
receptor expression in the peripheral 
nerve. Glia. 2010;58(14):1701-1709. 
DOI: 10.1002/glia.21041
[105] Boivin A, Pineau I, Barrette B, et al. 
Toll-like receptor signaling is critical for 
Wallerian degeneration and functional 
recovery after peripheral nerve 
injury. The Journal of Neuroscience. 
2007;27(46):12565-12576. DOI: 10.1523/
JNEUROSCI.3027-07.2007
[106] Atanasoski S, Scherer SS, 
Sirkowski E, et al. ErbB2 signaling in 
Schwann cells is mostly dispensable for 
maintenance of myelinated peripheral 
nerves and proliferation of adult 
Schwann cells after injury. The Journal 
of Neuroscience. 2006;26(7):2124-2131. 
DOI: 10.1523/JNEUROSCI.4594-05.2006
[107] Guertin AD, Zhang DP, Mak KS, 
Alberta JA, Kim HA. Microanatomy 
of axon/glial signaling during 
Wallerian degeneration. The Journal of 
Neuroscience. 2005;25(13):3478-3487. 
DOI: 10.1523/JNEUROSCI.3766-04.2005
[108] Ronchi G, Cillino M, 
Gambarotta G, et al. Irreversible changes 
occurring in long-term denervated 
Schwann cells affect delayed nerve 
repair. Journal of Neurosurgery. 
2017;127(4):843-856. DOI: 
10.3171/2016.9.JNS16140
[109] Mahanthappa NK, Anton ES, 
Matthew WD. Glial growth factor 
2, a soluble neuregulin, directly 
increases Schwann cell motility and 
indirectly promotes neurite outgrowth. 
The Journal of Neuroscience. 
1996;16(15):4673-4683. DOI: 10.1523/
jneurosci.16-15-04673.1996
[110] Fricker FR, Bennett DL. The 
role of neuregulin-1 in the response 
to nerve injury. Future Neurology. 
2011;6(6):809-822. DOI: 10.2217/
fnl.11.45
[111] Joshi AR, Holtmann L, Bobylev I, 
et al. Loss of Schwann cell plasticity in 
chronic inflammatory demyelinating 
polyneuropathy (CIDP). Journal of 
Neuroinflammation. 2016;13(1):255. 
DOI: 10.1186/s12974-016-0711-7
[112] Zochodne DW. The challenges 
and beauty of peripheral nerve 
regrowth. Journal of the Peripheral 
Nervous System. 2012;17:1-18. DOI: 
10.1111/j.1529-8027.2012.00378.x
[113] Painter MW, Brosius Lutz A, 
Cheng YC, et al. Diminished Schwann 
cell repair responses underlie 
age-associated impaired axonal 
regeneration. Neuron. 2014;83(2):331-
343. DOI: 10.1016/j.neuron.2014.06.016
[114] Frohnert PW, Stonecypher MS, 
Carroll SL. Constitutive activation 
of the neuregulin-1/ErbB receptor 
signaling pathway is essential for the 
proliferation of a neoplastic Schwann 
cell line. Glia. 2003;43(2):104-118. DOI: 
10.1002/glia.10232
[115] Fallon KB, Havlioglu N, 
Hamilton LH, Cheng TPH, 
Carroll SL. Constitutive activation 
of the neuregulin-1/erbB signaling 
pathway promotes the proliferation of 
a human peripheral neuroepithelioma 
cell line. Journal of Neuro-Oncology. 
2004;66(3):273-284. DOI: 10.1023/B:N
EON.0000014521.28294.84
[116] Huijbregts RPH, Roth KA, 
Schmidt RE, Carroll SL. Hypertrophic 
neuropathies and malignant peripheral 
nerve sheath tumors in transgenic 
Schwann Cells
20
mice overexpressing glial growth 
factor β3 in myelinating Schwann 
cells. The Journal of Neuroscience. 
2003;23(19):7269-7280. DOI: 10.1523/
jneurosci.23-19-07269.2003
[117] Tapinos N, 
Ohnishi M, Rambukkana A. ErbB2 
receptor tyrosine kinase signaling 
mediates early demyelination induced 
by leprosy bacilli. Nature Medicine. 
2006;12(8):961-966. DOI: 10.1038/
nm1433
[118] Fledrich R, Stassart RM, Klink A, 
et al. Soluble neuregulin-1 modulates 
disease pathogenesis in rodent models of 
Charcot-Marie-Tooth disease 1A. Nature 
Medicine. 2014;20(9):1055-1061. DOI: 
10.1038/nm.3664
[119] Manole E, Bastian A, 
Ristoiu V, Zurac S, Neagu M. The effects 
of exogenous modulation on the 
peripheral nerve regeneration after 
injury and primary 
surgical repair. Biomedical 
Journal of Scientific & Technical 
Research. 2018;4(3):1-5. DOI: 10.26717/
bjstr.2018.04.0001043
